Just Launched! DIA NOW delivering Always-On Insights

Making the intersection of healthcare accessible anytime, anywhere, across any device.
Start Exploring
Medical Affairs & Medical Writing: A Leading Role for Preparing and Submitting Clinical Documents in ICH Member China

We are in a time of revolution, and face both opportunities and challenges, but medical writers remain the key coordinators and contributors to dossier submission preparation.
Read More
PODCAST: Challenges & Opportunities for South Africa's New Regulatory System

Professor Sam Salek discusses the challenges and opportunities for enhanced regulatory practices in South Africa.
Listen Now
Pre-Analytics in Individualized Oncology: Biomarkers with the Goal in Mind

Major theoretical advantages are use of efficacious drugs with better outcomes, fewer adverse events from ineffective drugs, and lower cost with higher value for patients.
Read More
DIA会员如何使您受益?
与全球有影响力的人士联系,发现传达影响力变革的方式
获取新知识,使您保持在医疗保健对话的最前沿
通过一流的学习课程推进职业发展目标
打开通向新途径的大门,提升领导力
扩大人际网络,结交全球同行,互相实时给予支持
Christi Marsh
“DIA迅速成为一个不仅对教育,同时网络和领导力提升也具有价值的场所。如今,它就像一个专业人员的大家庭,我真的不能没有它。“
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“对我而言,DIA是一个非常特别的机会,可以表达我的观点,并倾听来自不同监管机构、行业和学术界的同事的意见。 我们都聚集在一起,公开、自由地讨论重要议题。 另外,它很有趣!”
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Christi Marsh
“DIA迅速成为一个不仅对教育,同时网络和领导力提升也具有价值的场所。如今,它就像一个专业人员的大家庭,我真的不能没有它。“
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“对我而言,DIA是一个非常特别的机会,可以表达我的观点,并倾听来自不同监管机构、行业和学术界的同事的意见。 我们都聚集在一起,公开、自由地讨论重要议题。 另外,它很有趣!”
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
全球论坛,DIA数字杂志
网罗医疗保健产品在全球以及区域范围内发现、开发、监管、监督、营销方面的专家观点,涵盖思想领袖的采访与教育活动的专题摘要。
DIA播客频道
探索生命科学领导者的思想,分享对治疗发展领域当前问题的观点,以及潜在的未来发展之路。